The TacroType test provides actionable genetic insights to help clinicians understand how individual patients metabolize tacrolimus
The initiative, funded entirely under the company’s CSR programme, is expected to reach over a million lives
Under the deal, Vivtex will license select oral drug-delivery technologies to Novo Nordisk
Asahi Kasei is consistently pursuing its strategy of building a focused, sustainable specialty pharmaceutical platform for immunocompromised and medically complex patient groups
The new solution combines Watchmaker Genomics’ high-performance NGS chemistry with Volta’s digital fluidics platform
NCFB is a chronic lung condition where damaged airways cause persistent coughing and mucus production
CagriSema produced a 23% weight loss at 84 weeks, versus 25.5% for tirzepatide
UBT251 appeared to have a safe and well-tolerated profile consistent with incretin-based therapies
This partnership represents a systemic shift from awareness to large-scale action for 57 lakh children
The study is a collaboration between AIM, AstraZeneca, and Erasmus Medical Center in the Netherlands
Subscribe To Our Newsletter & Stay Updated
